KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) Cost of Revenue: 2009-2024

Historic Cost of Revenue for Exact Sciences (EXAS) over the last 16 years, with Dec 2024 value amounting to $894.1 million.

  • Exact Sciences' Cost of Revenue rose 21.13% to $266.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.25%. This contributed to the annual value of $894.1 million for FY2024, which is 8.01% up from last year.
  • According to the latest figures from FY2024, Exact Sciences' Cost of Revenue is $894.1 million, which was up 8.01% from $827.8 million recorded in FY2023.
  • Over the past 5 years, Exact Sciences' Cost of Revenue peaked at $929.6 million during FY2022, and registered a low of $589.9 million during FY2020.
  • Moreover, its 3-year median value for Cost of Revenue was $894.1 million (2024), whereas its average is $883.9 million.
  • In the last 5 years, Exact Sciences' Cost of Revenue soared by 53.16% in 2020 and then fell by 10.95% in 2023.
  • Over the past 5 years, Exact Sciences' Cost of Revenue (Yearly) stood at $589.9 million in 2020, then skyrocketed by 46.10% to $861.9 million in 2021, then climbed by 7.86% to $929.6 million in 2022, then declined by 10.95% to $827.8 million in 2023, then grew by 8.01% to $894.1 million in 2024.